Does ANAMORELIN Cause Interstitial lung disease? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Interstitial lung disease have been filed in association with ANAMORELIN. This represents 10.0% of all adverse event reports for ANAMORELIN.
13
Reports of Interstitial lung disease with ANAMORELIN
10.0%
of all ANAMORELIN reports
7
Deaths
10
Hospitalizations
How Dangerous Is Interstitial lung disease From ANAMORELIN?
Of the 13 reports, 7 (53.8%) resulted in death, 10 (76.9%) required hospitalization, and 5 (38.5%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ANAMORELIN. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does ANAMORELIN Cause?
Malignant neoplasm progression (28)
Decreased appetite (14)
Oedema peripheral (9)
Pyrexia (9)
Non-small cell lung cancer (8)
Anaemia (7)
Hyperglycaemia (6)
Hypothyroidism (6)
Nausea (6)
Platelet count decreased (6)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which ANAMORELIN Alternatives Have Lower Interstitial lung disease Risk?
ANAMORELIN vs ANASTROZOLE
ANAMORELIN vs ANDEXANET ALFA
ANAMORELIN vs ANDROGEL
ANAMORELIN vs ANETHOLTRITHION
ANAMORELIN vs ANGIOTENSIN II